Laihinen A - Search Results

1

Positron emission tomography demonstrates dopamine D2 receptor supersensitivity in the striatum of patients with early Parkinson's disease.

Rinne UK, Laihinen A, Rinne JO, Någren K, Bergman J, Ruotsalainen U. Rinne UK, et al. Among authors: laihinen a. Mov Disord. 1990;5(1):55-9. doi: 10.1002/mds.870050114. Mov Disord. 1990. PMID: 2136932

2

PET studies on brain monoamine transporters with carbon-11-beta-CIT in Parkinson's disease.

Laihinen AO, Rinne JO, Någren KA, Lehikoinen PK, Oikonen VJ, Ruotsalainen UH, Ruottinen HM, Rinne UK. Laihinen AO, et al. J Nucl Med. 1995 Jul;36(7):1263-7. J Nucl Med. 1995. PMID: 7790953 Free article.

3

PET studies on dopamine D1 receptors in the human brain with carbon-11-SCH 39166 and carbon-11-NNC 756.

Laihinen AO, Rinne JO, Ruottinen HM, Någren KA, Lehikoinen PK, Oikonen VJ, Ruotsalainen UH, Rinne UK. Laihinen AO, et al. J Nucl Med. 1994 Dec;35(12):1916-20. J Nucl Med. 1994. PMID: 7989969 Free article. Clinical Trial.

4

Striatal [18F]fluorodopa utilization after COMT inhibition with entacapone studied with PET in advanced Parkinson's disease.

Ruottinen HM, Rinne JO, Ruotsalainen UH, Bergman JR, Oikonen VJ, Haaparanta MT, Solin OH, Laihinen AO, Rinne UK. Ruottinen HM, et al. Among authors: laihinen ao. J Neural Transm Park Dis Dement Sect. 1995;10(2-3):91-106. doi: 10.1007/BF02251225. J Neural Transm Park Dis Dement Sect. 1995. PMID: 9620057 Clinical Trial.

5

Positron emission tomography of brain dopamine D-2 receptors with 11C-raclopride in early Parkinson's disease.

Laihinen A, Rinne JO, Någren K, Bergman J, Haaparanta M, Solin O, Ruotsalainen U, Rinne UK. Laihinen A, et al. Acta Radiol Suppl. 1991;376:151. Acta Radiol Suppl. 1991. PMID: 1666759 No abstract available.

6

Positron emission tomography of brain dopamine D-1 receptors with 11C-SCH 23390 in Parkinson's disease.

Rinne JO, Laihinen A, Någren K, Bergman J, Haaparanta M, Solin O, Ruotsalainen U, Rinne UK. Rinne JO, et al. Among authors: laihinen a. Acta Radiol Suppl. 1991;376:152. Acta Radiol Suppl. 1991. PMID: 1666760 No abstract available.

7

Brain substance P receptors in Parkinson's disease.

Tenovuo O, Kolhinen O, Laihinen A, Rinne UK. Tenovuo O, et al. Among authors: laihinen a. Adv Neurol. 1990;53:145-8. Adv Neurol. 1990. PMID: 1700582

8

[18F]-6-fluorodopa PET scanning in Parkinson's disease after selective COMT inhibition with nitecapone (OR-462).

Laihinen A, Rinne JO, Rinne UK, Haaparanta M, Ruotsalainen U, Bergman J, Solin O. Laihinen A, et al. Neurology. 1992 Jan;42(1):199-203. doi: 10.1212/wnl.42.1.199. Neurology. 1992. PMID: 1734304

9

A post-mortem study on striatal dopamine receptors in Parkinson's disease.

Rinne JO, Laihinen A, Lönnberg P, Marjamäki P, Rinne UK. Rinne JO, et al. Among authors: laihinen a. Brain Res. 1991 Aug 9;556(1):117-22. doi: 10.1016/0006-8993(91)90554-9. Brain Res. 1991. PMID: 1834312

10

PET demonstrates different behaviour of striatal dopamine D-1 and D-2 receptors in early Parkinson's disease.

Rinne JO, Laihinen A, Någren K, Bergman J, Solin O, Haaparanta M, Ruotsalainen U, Rinne UK. Rinne JO, et al. Among authors: laihinen a. J Neurosci Res. 1990 Dec;27(4):494-9. doi: 10.1002/jnr.490270409. J Neurosci Res. 1990. PMID: 1981915

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

34 results

Search Page

Filters